Longeveron Inc.
LGVN · Miami, FL
Works in Cardiovascular · Genetic & rare · Infectious disease · Metabolic & endocrine · Neurology · Psychiatry · Respiratory
Longeveron Inc. is a clinical trial sponsor based in Miami, FL, listed as LGVN. It has 1 active clinical trial with 40 planned participants, across 7 therapeutic areas. Since 2021 it has completed 5 trials and stopped 2 early.
Trial track record · since 2021
Financials · LGVN
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Longeveron Inc
Longeveron Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 40 planned participants, in Cardiovascular, Genetic & rare, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 5 trials and stopped 2 early.
Longeveron Inc is based in Miami, FL and is listed as LGVN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Longeveron Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-06-25.
Approve Suite is not affiliated with Longeveron Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.